Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 41: 1864-1869, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spurr, N. K.
Right arrow Articles by Smith, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spurr, N. K.
Right arrow Articles by Smith, C. A.

Clinical Chemistry, Vol 41, 1864-1869, Copyright © 1995 by American Association for Clinical Chemistry

Polymorphisms in drug-metabolizing enzymes as modifiers of cancer risk

NK Spurr, AC Gough, FI Chinegwundoh and CA Smith
Human Genetic Resources Laboratory, Imperial Cancer Research Fund, Clare Hall Laboratories, South Mimms, Herts, UK.

The identification of low-penetrance genes, the polymorphisms of which increase an individual's risk of developing cancer, are likely to be extremely important in the general population. In this report we analyzed two genes involved in detoxification. In a number of loci, we identified polymorphic variation correlating with the expression of the gene product. We analyzed two such loci, the cytochrome P-450 gene CYP2D6 and the N-acetyltransferase 2 (NAT2) genes, in patients with bladder and colon cancer, respectively. We observed no statistically significant associations between the control and cancer populations; however, there was a small increase in heterozygote number in bladder cancer.


The following articles in journals at HighWire Press have cited this article:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. M. de Jong, I. M. Nolte, G. J. te Meerman, W. T. A. van der Graaf, E. G. E. de Vries, R. H. Sijmons, R. M. W. Hofstra, and J. H. Kleibeuker
Low-penetrance Genes and Their Involvement in Colorectal Cancer Susceptibility
Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1332 - 1352.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Sachse, G. Smith, M. J.V. Wilkie, J. H. Barrett, R. Waxman, F. Sullivan, D. Forman, D. T. Bishop, and C.R. Wolf
A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer
Carcinogenesis, November 1, 2002; 23(11): 1839 - 1850.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. Zhou, G. Liu, S. W. Thurston, L. L. Xu, D. P. Miller, J. C. Wain, T. J. Lynch, L. Su, and D. C. Christiani
Genetic Polymorphisms in N-acetyltransferase-2 and Microsomal Epoxide Hydrolase, Cumulative Cigarette Smoking, and Lung Cancer
Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 15 - 21.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
C. Chen, S. Ricks, D. R. Doody, E.D. Fitzgibbons, P. L. Porter, and S. M. Schwartz
N-Acetyltransferase 2 polymorphisms, cigarette smoking and alcohol consumption, and oral squamous cell cancer risk
Carcinogenesis, December 1, 2001; 22(12): 1993 - 1999.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov
Genetic Polymorphism of CYP Genes, Alone or in Combination, as a Risk Modifier of Tobacco-related Cancers
Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 3 - 28.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. W. Hein, M. A. Doll, A. J. Fretland, M. A. Leff, S. J. Webb, G. H. Xiao, U.-S. Devanaboyina, N. A. Nangju, and Y. Feng
Molecular Genetics and Epidemiology of the NAT1 and NAT2 Acetylation Polymorphisms
Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 29 - 42.
[Abstract] [Full Text]


Home page
Mol Hum ReprodHome page
H. Baranova, M. Canis, T. Ivaschenko, E. Albuisson, R. Bothorishvilli, V. Baranov, P. Malet, and M.A. Bruhat
Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis
Mol. Hum. Reprod., July 1, 1999; 5(7): 636 - 641.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Welfare, A. M. Adeokun, M. F. Bassendine, and A. K. Daly
Polymorphisms in GSTP1, GSTM1, and GSTT1 and Susceptibility to Colorectal Cancer1
Cancer Epidemiol. Biomarkers Prev., April 1, 1999; 8(4): 289 - 292.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.